Molecular cytogenetics of bone and soft tissue tumors

Cancer Genetics and Cytogenetics

Volumn 95, Issue 1, 1997, Pages 67-73

  Geurts van Kessel, A ^a   Dos Santos, N R ^a   Simons, A ^a   De Bruijn, D ^a   Forus, A ^b   Fodstad, O ^b   Myklebost, O ^b   Balemans, M ^a   Baats, E ^a   Olde Weghuis, D ^a   Suijkerbuijk, R F ^a   Van den Berg, E ^c   Molenaar, W M ^c   De Leeuw, B ^a  

^a University Hospital   (Netherlands)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE TUMOR; CANCER GENETICS; GENETIC ANALYSIS; HUMAN; PRIORITY JOURNAL; REVIEW; SOFT TISSUE TUMOR; SYNOVIAL SARCOMA;

EID: 0003156072     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00241-5     Document Type: Article

References (68)

1. Enzinger FM, Weiss SW (1988): Soft Tissue Tumors. CV Mosby, St. Louis.
2. Sandberg AA, Bridge JA (1994): The Cytogenetics of Bone and Soft Tissue Tumors. RG Landers, Austin.
3. Sandberg AA (1990): The Chromosomes in Human Cancer and Leukemia. 2nd ed. Elsevier, New York.
4. Mitelman F (1994): Catalog of Chromosome Aberrations in Cancer, 4th ed. Alan R. Liss, New York.
5. Sreekantaiah C, Ladanyi M, Rodriguez E, Chagnati RSK (1994): Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification and molocular mechanisms. Am J Pathol 144:1121-1134.
6. Meltzer P, Kinzler K, Vogelstein B. Trent JM (1986): Gene amplification in cancer: a molecular cytogenetic approach. Cancer Genet Cytogenet 19:93-99.
7. Dal Gin P, Kools P, Sciot R, De Wever I, Van Damme B, Van de Ven W, Van den Berghe H (1993): Cytogenetic and fluorescence in situ hybridization of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet 68:85-90.
8. Pedeutour F, Suijkerbuijk RF, Forus A, van Gaal J, van de Klundert W, Coindre JM, Nicolo G, Collin F, van Haelst U, Huffermann K, Turc-Carel C (1994): Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosom Cancer 10:85-94.
9. Huvos AG (1991); Bone Tumors. Diagnosis, Prognosis, and Treatment. 2nd ed. WB Saunders, Philadelphia.
10. Mertens F, Mandahl N, Orndal C, Baldetorp B, Bauer HCF, Rydholm A, Wiebe T, Willen H. Åkerman M, Heim S, Mitelman F (1993): Cytogenetic findings in 33 osteosarcomas, Int J Cancer 55:44-50.
11. Tarkkanen M, Kaipainen A, Karaharju E, Bohling T, Szymanska J, Helio H, Kivioja A, Elomaa I, Knuutila S (1993): Cytogenetic study of 249 consecutive patients examined for a bone tumor. Cancer Genet Cytogenet 68:1-21.
12. Fletcher JA, Gebhardt MC, Kozahevrich HP (1994): Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings and double minute chromosomes. Cancer Genet Cytogenet 71:81-88.
13. Schmidt D, Harms D (1991): Tumors of synovial tissue, In: Tumors and Tumorlike Lesions of Soft Tissue, Ninfo V, Chung EB, Cavazzana AO, eds. Churchill Livingstone, New York, pp. 179-194.
14. Turc-Carel C, Dal Cin P, Limon J, Rao U, Li FP, Corson JM, Zimmerman R, Parry DM, Cowan JM, Sandberg AA (1987): Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci USA 84:1981-1985.
15. Mandahl N, Limon J, Mertens F, Nedoszytko B, Gibas Z, Denis A, Willén H, Rydholm A, Szadowska A, Kreicbergs A, Rys J, Debiec-Rychter M, Mitelman F (1995): Nonrandom secondary chromosome aberrations in synovial sarcomas with t(X;18). Int J Oncol 7:495-499.
16. Knight JC, Reeves BR, Kearney L, Monaco AP, Lehrach H, Cooper CS (1992): Localization of the synovial sarcoma t(X;18)(p11.2;q11.2) breakpoint by fluorescence in situ hybridization. Hum Mol Genet 1:633-637.
17. de Leeuw B, Berger W, Sinke RJ, Suijkerbuijk RF, Gilgenkrantz S, Geraghty MT, Valle D, Monaco AP, Lehrach H, Ropers HH, Geurts van Kessel A (1993): Identification of a yeast artificial chromosome (YAC) spanning the synovial sarcoma-specific t(X;18)(p11.2;q11.2) breakpoint. Genes Chromosom Cancer 6:182-189.
18. de Leeuw B, Suijkerbuijk RF, Olde Weghuis D, Meloni AM, Stenman G, Kindblom LG, Balemans M, van den Berg E, Molenaar WM, Sandberg AA, Geurts van Kessel A (1994): Distinct Xp11.2 breakpoint regions in synovial sarcoma revealed by metaphase and interphase FISH: relationship to histologic subtypes. Cancer Genet Cytogenet 73:89-94.
19. de Leeuw B, Suijkerbuijk RF, Balemans M, Sinke RJ, de Jong B, Molenaar WM, Meloni AM, Sandberg AA, Geraghty M, Hofker M, Ropers HH, Geurts van Kessel A (1993): Sublocalization of the synovial sarcoma-associated t(X;18) chromosomal breakpoint in Xp11.2 using cosmid cloning and fluorescence in situ hybridization. Oncogene 8:1457-1463.
20. de Leeuw B, Balemans M, Olde Weghuis D, Seruca R, Janz M, Geraghty MT, Gilgenkrantz S, Ropers HH, Geurts van Kessel A (1994): Molecular cloning of the synovial sarcoma-specific translocation (X;18)(p11.2;q11.2) breakpoint. Hum Mol Genet 3:745-749.
21. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM-L, Gusterson BA, Cooper CS (1994): Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nature Genet 7:502-508.
22. de Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A (1995): Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas. Hum Mol Genet 4:1097-1099.
23. Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, Shipley J, Gusterson BA, Cooper CS (1995): Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 14:2333-2340.
24. Pawson T, Schlessinger J (1993): SH2 and SH3 domains. Curr Biol. 3:434-442.
25. de Bruijn DRH, Baats E, Zechner U, de Leeuw B, Balemans M, Olde Weghuis D, Hameister H, Geurts van Kessel A (1996): Isolation and characterization of the mouse homolog of SYT, a gene implicated in the development of human synovial sarcomas. Oncogene 13:643-648.
26. Margolin JF, Friedman JR, Meyer WK-H, Vissing H, Thiesen H-J, Rauscher FJ (1994): Krüppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci USA 91:4509-4513.
27. Sahin U, Türeci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M (1995): Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92:11810-11813.
28. de Leeuw B, Balemans M, Geurts van Kessel A (1996): A Novel Krüppel-associated box containing SSX gene (SSX3) on the human X chromosome is not implicated in t(X;18)-positive synovial sarcomas. Cytogenet Cell Genet 73:179-183.
29. Chand A, Clark J, Cooper CS, Craig IW (1995): Long-range organization of reiterated sequences, including the SSX1 cDNA, at the OATL1 cluster in Xp11.23. Genomics 30:545-552.
30. Ladanyi M (1995): The emerging molecular genetics of sarcoma translations. Diagn Mol Pathol 4:162-173.
31. Olde Weghuis D, Stoepker MEJ, de Leeuw B, van den Berg E, Suijkerbuijk RF, Molenaar WM, de Jong B, Geurts van Kessel A (1994): A synovial sarcoma with a complex t(X;18;5;4) and a break in the ornithine aminotransferase (OAT)L1 cluster on Xp11.2. Genes Chromosom Cancer 9:288-291.
32. Fligman I, Lonardo F, Jhanwar SC, Gerald WL, Woodruff J, Ladanyi M (1995): Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am J Pathol 147:1592-1599.
33. Shipley J, Crew J, Birdsall S, Gill S, Clark J, Fisher C, Kelsey A, Nojima T, Sonobe H, Cooper C, Gusterson B (1996): Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma. Am J Pathol 148:559-567.
34. Janz M, de Leeuw B, Olde Weghuis D, Werner M, Nolte M, Geurts van Kessel A, Nordheim A, Hipskind RA (1995): Interphase cytogenetic analysis of distinct X-chromosomal translocation breakpoints in synovial sarcoma, J Pathol 175:391-396.
35. Renwick PJ, Reeves BR, Dal Cin P, Fletcher CDM, Kempski H, Sciot R, Kazmierczak B, Jani H, Sonobe H, Knight JC (1995): Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2, with implications for the histologic sub-classification of synovial sarcoma. Cytogenet Cell Genet 70:58-63.
36. Brison O (1993): Gene amplification and tumor progression. Biochim Biophys Acta 1155:25-41.
37. Ozaki T, Ikeda S, Kawai A, Inoue H, Oda T (1993): Alterations of retinoblastoma susceptibility gene accompanied by c-MYC amplification in human bone and soft tissue tumors. Mol Cell Biol 39:235-242.
38. Barrios C, Castrena JS, Ruiz J, Kreicbergs A (1994): Amplification of the c-MYC proto-oncogene in soft tissue sarcomas, Oncology 51:13-17.
39. Leach FS, Tokino T, Meltzer PS, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B (1993): p53 mutations and MDM2 amplification in human soft tissue sarcoma, Cancer Res 53:2231-2234.
40. Forus A, Flørenes VA, Maelandsmo GM, Meltzer PS, Fodstad Ø, Myklebost O (1993): Mapping of amplification units in the q13-14 region of human chromosome 12 in human sarcoma: some amplica do not include MDM2. Cell Growth Diff 4:1065-1070.
41. Smith SH, Weiss SW, Jankowski SA, Coccia MA, Meltzer PS (1993): SAS amplification in soft tissue sarcomas. Cancer Res 52:3746-3749.
42. Momand J, Zambetti GP, Olson DC, George DL, Levine AJ (1992): The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
43. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH (1993): MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 53:16-18.
44. Hoogerwerf WA, Hawkins AL, Perlman EJ, Griffin CA (1994): Chromosome analysis of nine osteosarcomas. Genes Chromosom Cancer 9:88-92.
45. Miller CW, Aslo A, Tsay C, Slamon D, Ishizaki K, Toguschida J, Yamamuro T, Lampkin B, Koeffler HP (1990): Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50:7950-7954.
46. Mulligan LM, Matlaschewski GJ, Scrable HJ, Cavenee WK (1990): Mechanism of p53 loss in human sarcoma. Proc Natl Acad Sci USA 87:5863-5867.
47. Andreassen A, Øyjord T, Hovig E, Holm R, Florenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL, Fodstad Ø (1993): p53 abnormalities in different subtypes of human sarcomas. Cancer Res 53:468-471.
48. Toguschida J, Ishizaki K, Sasaki MS, Ikenaga M, Sugimoto M, Kotoura Y, Yamamuro T (1988): Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in development of osteosarcoma. Cancer Res 48:3939-3943.
49. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Kotoura Y, Yamamoto T (1994): Mutation spectrum of the retinoblastoma gene in osteosarcoma. Cancer Res 54:3042-3048.
50. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992): Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
51. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM (1994): Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160.
52. Suijkerbuijk RF, Olde Weghuis DEM, van den Berg M, Pedeutour F, Forus A, Myklebost O, Glier C, Turc-Carel C, Geurts van Kessel A (1994): Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well differentiated liposarcomas. Genes Chromosom Cancer 9:292-295.
53. Cher ML, MacGrogan P, Bookstein R, Brown JA, Jenkins JB, Jensen RH (1994): Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosom Cancer 11:153-162.
54. Szymanski J, Mandahl N, Mertens F, Tarkkanen M, Karaharju E, Knuutila S (1996): Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: a combined cytogenetic and comparative genomic hybridization study. Genes Chromosom Cancer 16:31-34.
55. Szymanski J, Tarkkanen M, Wiklund T, Virolainen M, Blomqvist C, Asko-Seljavaara, Tukiainen E, Elomaa I, Knuutila S (1996): Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosom Cancer 15:89-94.
56. Forus A, Olde Weghuis D, Smeets D, Fodstad Ø, Myklebost O, Geurts van Kessel A (1995): Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosom Cancer 14:8-14.
57. Forus A, Olde Weghuis D, Smeets D, Fodstad Ø, Myklebost O, Geurts van Kessel A (1995): Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas. Genes Chromosom Cancer 14:15-21.
58. Forus A, Schmitt JM, Pedeutour F, Turc-Carel C, Meltzer PS, Fodstad Ø, Myklebost O (1994): Amplification of 12q13-14 in human sarcomas: is there a common selective gene, or are different mechanisms important in different sets of tumors? Cytogenet Cell Genet 67:269.
59. Maelandsmo GM, Berner JM, Flørenes VA, Forus A, Hovig E, Fostad Ø, Myklebost O (1995): Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas - relationship to amplification and mRNA levels of CDK4 and CCND1. Brit J Cancer 72:393-398.
60. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT (1993): Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 53:5535-5541.
61. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA (1992): Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
62. Berner JM, Forus A, Kahloun A, Meltzer PS, Fodstad Ø, Myklebost O (1997): Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosom Cancer (in press).
63. Schröck E, Thiel G, Lozonova T, du Manoir S, Meffert MC, Jauch A, Speicher MR, Nurnberg P, Vogel S, Janisch W, Donis-Keller H, Ried T, Witkowski R, Cremer T (1994): Comparative genomic hybridization of human malignant glioma reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 144:1203-1218.
64. Engelkamp D, Schafer BW, Mattei MG, Erne P, Heizmann CW (1993): Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the previously unreported calcium-binding proteins S100D and S100E. Proc Natl Acad Sci USA 90:6547-6551.
65. Dracopoli NC, Bruns GAP, Brodeur GM, Candes GM, Matise TC, Seldin MF, Vance JM, Weith A (1994): Report of the first international workshop on human chromosome 1 mapping. Cytogenet Cell Genet 67:144-165.
66. Weterman MAJ, Stoopen GM, van Muijen GNP, Kuznicki J, Ruiter DJ, Bloemers HPJ (1992): Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. Cancer Res 52:1291-1296.
67. Tarkkanen M, Karhu R, Kalloniemi A, Elomaa I, Kivioja AH, Nevalainen J, Böhling T, Karaharju E, Hyytinen E, Knuutila S, Kalloniemi OP (1996): Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 55:1334-1338.
68. Bijlsma EK, Leenstra S, Westerveld A, Bosch D, Hulsebos TJM (1994): Amplification of the anonymous marker D17S67 in malignant astrocytomas. Genes Chromosom Cancer 9:148-152.